Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
24,582
Total Claims
$1.4M
Drug Cost
1,357
Beneficiaries
$1,014
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
-39%
Opioid rate vs peers
0.8% vs 1.3% avg
-75%
Cost per patient vs peers
$1,014 vs $4,034 avg
-47%
Brand preference vs peers
5.0% vs 9.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.8%
Opioid Rate
197
Opioid Claims
$1,482
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,228 claims · $965K
Generic: 23,318 claims · $409K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Interferon Beta-1a | 24 | $194K |
| Galcanezumab-Gnlm | 225 | $157K |
| Interferon Beta-1b | 13 | $122K |
| Dimethyl Fumarate | 17 | $101K |
| Rivastigmine | 533 | $69K |
| Pimavanserin Tartrate | 13 | $58K |
| Milnacipran Hcl | 116 | $54K |
| Levetiracetam | 34 | $39K |
| Pregabalin | 1,162 | $33K |
| Lamotrigine | 22 | $30K |
| Gabapentin | 3,585 | $27K |
| Memantine Hcl | 1,603 | $23K |
| Vortioxetine Hydrobromide | 44 | $23K |
| Carbamazepine | 116 | $19K |
| Rasagiline Mesylate | 117 | $19K |
Prescribing Profile
129
Unique Drugs
21.0
Anomaly Score
Patient Profile
71
Avg Age
63%
Female
2.31
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About